PRIMARY STUDY
A Survey of Cannabis Use among Patients with Inflammatory Bowel Disease (IBD)
Key Findings: Data showed that more than 80% of the participating patients saw improvement in their symptoms.
Type of Study: Meta-analysis
Study Sample Size: 162
Study Result: Positive
Research Location(s): United States
Year of Pub: 2023
Cannabinoids Studied: Cannabinoid (unspecified)
Phytocannabinoid Source: Unspecified
Citation: Velez-Santiago A, et al. A Survey of Cannabis Use among Patients with Inflammatory Bowel Disease (IBD). Int J Environ Res Public Health. 2023; 20:(unknown pages). doi: 10.3390/ijerph20065129
Authors: Velez-Santiago A, Alvarez-Torres E, Martinez-Rodriguez R, Candal-Rivera E, Muniz-Camacho L, Ramos-Burgos L, Torres EA
